Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1984-11-21
pubmed:abstractText
Release of pancreatic polypeptide (PP) after a meal is biphasic, with an early transient peak believed to be under cholinergic control, and a secondary, prolonged intestinal phase thought to be mediated by hormones. Endogenous release of PP was stimulated by intraduodenal oleate (6.8 mmol/hr) or by intravenous administration of pure cholecystokinin-33 (CCK-33, 0.1 micrograms/kg/hr) in five dogs. Radioimmunoassay measurements of plasma concentrations of PP and CCK-33 were compared by linear regression analysis before and after vagotomy. Correlations between plasma concentrations of PP and CCK-33 before vagotomy (r = 0.83 [oleate], r = 0.97 [IV-CCK-33]) and after vagotomy (r = 0.92 [oleate], r = 0.92 [IV-CCK-33]) were highly significant. Changes in plasma concentrations of PP relative to a particular increment in plasma CCK-33 (before vagotomy) were similar, whether stimulated by oleate or by exogenous CCK-33. After vagotomy, less PP was released relative to a change in plasma CCK-33 (stimulated by oleate or by exogenous CCK-33), but the PP response relative to a change in plasma CCK-33 induced by the two stimuli remained remarkably similar. These results provide evidence that the intestinal phase of physiologic release of PP is mediated to a large extent through release of CCK.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-492243, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-5073222, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-5666100, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-57509, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-6618104, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-675146, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-680498, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-7054040, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-7058511, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-7084608, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-7194753, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-7215307, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-7372788, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-7419006, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-7468804, http://linkedlifedata.com/resource/pubmed/commentcorrection/6486910-758592
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0003-4932
pubmed:author
pubmed:issnType
Print
pubmed:volume
200
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
600-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
Physiologic role of cholecystokinin in the intestinal phase of pancreatic polypeptide release.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't